DexCom, Inc. vs ArcelorMittal SA — how do they compare? DexCom, Inc. trades at $77.62 (market cap $28.06B), while ArcelorMittal SA trades at $66.21 (market cap $50.29B). The key difference: ArcelorMittal SA is the larger of the two by market cap, and ArcelorMittal SA pays a 0.89% dividend while DexCom, Inc. pays none. Which is the better fit depends on your goals.
| DXCM | MT | |
|---|---|---|
Market Cap | $28.06B | $50.29B |
Sector | Health | Basic Materials |
52-Week High | $89.53 | $71.65 |
52-Week Low | $54.84 | $30.39 |
Enterprise Value | $27.03B | $59.61B |
Dividend Yield | — | 0.89% |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
ArcelorMittal (MT) trades at $66.99, up 1.62% today, with strong technical momentum and bullish moving average signals. The company has delivered three consecutive earnings beats, with Q2 2026 EPS expected at $1.17. Revenue declined from $79.8B in 2022 to $61.4B in 2025, but net income improved to $3.2B, reflecting margin expansion. Recent developments include a strategic AI collaboration with AWS and ongoing share buybacks.
The outlook remains positive with analyst consensus favoring Buy ratings (50%), though risks include declining revenue trends and heavy capital expenditures. The stock's valuation appears reasonable with P/E of 17.7 and P/B of 0.92, trading below book value. Key catalysts include steel import controls in Europe and expansion projects, while headwinds involve China weakness and decarbonization costs.
Trailing returns across standard periods
Latest headlines on both assets
Dexcom designs and commercializes continuous glucose monitoring systems for diabetics. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to include the disposable sensor and the durable receiver.
Read more on DXCM →ArcelorMittal SA is involved in the steel industry. The company's operating segments include NAFTA
Read more on MT →